Pfizer & Astellas’ Padcev plus Keytruda shows long-term efficacy in first-line treatment of locally advanced or metastatic urothelial cancer: New York Wednesday, February 12, 20 ...

Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...

Even when measured against a more comprehensive list, momentum outdid all of its rivals in 2024 and is shaping up for a repeat in 2025, according to data shared with MarketWatch by Piper Sandler's ...

Shares of Neuphoria Therapeutics Inc. soared more than 11% in premarket trading on Wednesday, propelling the micro-cap ...

Co's stock has reached a 52-week low, dipping to $85.71. This downturn reflects a significant shift from the previous year, with the pharmaceutical giant experiencing a 1-year change of -31.59%.

Trump Holds Call With Putin to Start Talks on Ending Ukraine War President Trump said he had “a lengthy and highly productive” call with President Vladimir Putin of Russia, their first ...

Request Sample of the Report on Global Cell Culture Hydrogel Market 2035 - The growth of the cell culture hydrogel market is driven by surge in prevalence of chronic diseases and aging population, ...

Dr. Patrick Heissler, CEO, SCRONA AG, discusses the company’s recently unveiled 128-nozzle electrohydrodynamic (EHD) printhead, which achieves a three-digit nozzle count in digital EHD technology for ...